Popular drug used to treat epilepsy, bipolar disorder recalled nationwide: Here’s why

Bionpharma Inc. has initiated a nationwide recall of its Divalproex Sodium delayed-release tablets. The prescription medication, commonly used to treat epilepsy and bipolar disorder, is being pulled from the market due to a manufacturing issue.

According to an FDA enforcement report, the recall stems from a packaging error. Foreign tablets and capsules were identified inside the affected product bottles, resulting in cross-contamination of medications. This poses a potential health risk to patients who rely on the drug for their treatment regimens.

The recall involves 500-mg tablets distributed in 500-count bottles. Patients currently using this medication should check their pill bottles and consult with their pharmacy or healthcare provider immediately to verify if their specific supply is part of this action. Do not stop taking prescribed medication without first speaking to a medical professional.

While the company has not provided a public comment regarding the incident, the FDA has prioritized the enforcement action. Patients who possess the recalled product are advised to return it to the place of purchase or follow established safety protocols for disposal of medical items. Staying informed about drug safety notices is a critical part of managing personal health.